Ozone treatment process for the removal of pharmaceuticals and personal care products in wastewater

This study investigated the degradability of pharmaceuticals and personal care products (PPCPs) by ozonation for the treatment of secondary effluent of a municipal wastewater treatment plant. A set of experiments were conducted in a laboratory using a pilot-scale process consisting of three flow-through reactors in series, by varying the ozone dose (1–9 mg L−1), the hydraulic retention time (5–15 min), and the concentration of ozone injected into the reactors (14–42 mg L−1). Thirty-seven PPCPs were detected in the secondary effluent, which belongs to the use categories of antibiotics, analgesics, antiarrhythmic agents, anticonvulsants, vasodilators, lipid modifying agents, anti-itch drugs, anti-psychotic drugs, insect repellents, bronchodilators, diuretics, peptic ulcer drugs, NMDA receptor antagonists, antifungal drugs, antimicrobial drugs, and antineoplastic agents. These PPCPs were broadly classified into five groups ranging from “sensitive” to ozone (O3) or “unstable” in the ozonation process, to the group of “insensitive” to O3 or “very stable” in the ozonation process. These groups are based on the PPCP concentrations after the ozone treatment and their limit of detection (LOD). Furthermore, this study examined comparatively the effects of the ozone dose, the retention (reaction) time, and the concentration of O3 supplied to the reactors on the degradability of the PPCPs.